NCT03610061 2024-04-12
RaDD
Austin Health
Phase 1 Completed
Clinical Trials
4 trialsNCT03310619 2024-04-04
PLATFORM
Celgene
Phase 1/2 Completed
NCT03685344 2021-10-26
Safety and Antitumor Activity Study of Loncastuximab Tesirine and Durvalumab in Diffuse Large B-Cell, Mantle Cell, or Follicular Lymphoma
ADC Therapeutics S.A.
Phase 1 Terminated
NCT02401048 2019-06-27
A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas
Pharmacyclics LLC.
Phase 1/2 Completed